Mark Murray
2017 - Arbutus Biopharma Corp
In 2017, Mark Murray earned a total compensation of $1.9M as President and Chief Executive Officer at Arbutus Biopharma Corp, a 9% decrease compared to previous year.
Compensation breakdown
| Bonus | $324,000 |
|---|---|
| Option Awards | $1,003,500 |
| Salary | $540,000 |
| Other | $47,794 |
| Total | $1,915,294 |
Murray received $1M in option awards, accounting for 52% of the total pay in 2017.
Murray also received $324K in bonus, $540K in salary and $47.8K in other compensation.
Rankings
In 2017, Mark Murray's compensation ranked 5,713th out of 14,666 executives tracked by ExecPay. In other words, Murray earned more than 61.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,713 out of 14,666 | 61st |
Division Manufacturing | 2,076 out of 5,772 | 64th |
Major group Chemicals And Allied Products | 644 out of 2,075 | 69th |
Industry group Drugs | 496 out of 1,731 | 71st |
Industry Pharmaceutical Preparations | 391 out of 1,333 | 71st |
Source: SEC filing on April 25, 2018.
Murray's colleagues
We found four more compensation records of executives who worked with Mark Murray at Arbutus Biopharma Corp in 2017.
News
Jones Soda CEO David Knight receives $1.4M in 2023
April 3, 2024
Jones Soda CEO Mark Murray's 2022 pay rises 5% to $406K
April 5, 2023
Jones Soda CEO Mark Murray's 2021 pay jumps 58% to $386K
April 1, 2022
Jones Soda CEO Mark Murray's 2020 pay falls 94% to $243K
April 1, 2021
Arbutus Biopharma Corp CEO Mark Murray's 2019 pay jumps 50% to $3.8M
April 24, 2020
Arbutus Biopharma Corp CEO Mark Murray's 2018 pay jumps 32% to $2.5M
April 23, 2019